About Dipanjan Banchur

Since he was in grade school, Dipanjan was interested in the stock market. This led to him obtaining a master’s degree in Finance and Accounting. Currently, as an investment analyst and financial journalist, Dipanjan has a strong interest in reading and analyzing emerging trends in financial markets. His goal is to help investors make the best investment decisions based on a fundamental approach.


Recent Articles By Dipanjan Banchur

: BRK.B |  News, Ratings, and Charts

Berkshire Hathaway (BRK.B) Earnings Alert: Key Insights for Investors

Berkshire Hathaway (BRK.B) will release its fourth-quarter results on February 22. The company is expected to report a year-over-year rise in earnings and revenue. I’ve discussed several key insights that investors must consider before its earnings release. Keep reading…
: PSA |  News, Ratings, and Charts

Should You Buy, Hold, or Sell Realty Income (O) and Public Storage (PSA) Ahead of Earnings?

REITs Public Storage (PSA) and Realty Income Corporation (O) are scheduled to release their fourth-quarter financials on February 21. We assess the two REIT’s fundamentals to determine how investors should position themselves before their numbers are reported. Read on…
: HD |  News, Ratings, and Charts

Home Depot (HD) Earnings Impact: Buy or Watch Moves?

World’s largest home improvement retailer, The Home Depot (HD), will release its fourth-quarter results on February 20. The company is expected to report a year-over-year decline in earnings and revenue. Therefore, should investors consider buying the stock ahead of its earnings? Read on to learn my view…
: VRTX |  News, Ratings, and Charts

Dominate the Market With 3 Biotech Stocks

The biotech industry’s growth prospects look promising due to considerable investments in research and development (R&D), an innovative drugs pipeline, government initiatives, the growing popularity of personalized medicine, drug approvals, expanding healthcare needs, etc. Amid this backdrop, investors could consider buying fundamentally strong biotech stocks Innoviva (INVA), Foghorn Therapeutics (FHTX), and Vertex Pharmaceuticals (VRTX). Keep reading…
: ANF |  News, Ratings, and Charts

This Week's Key Luxury Stock Gainers

The luxury goods industry appears well-positioned to benefit from changing consumer trends, rising disposable incomes, integration of advanced technologies, growing popularity of e-commerce platforms, ease of payments, etc. Amid this backdrop, investors could consider buying fundamentally strong luxury stocks The Buckle (BKE), Abercrombie & Fitch (ANF), and Vera Bradley (VRA). Keep reading…
: STLA |  News, Ratings, and Charts

STLA Earnings Impact: Buy or Hold Decision?

Hoofddorp, the Netherlands-based Stellantis (STLA), will release its full-year results on February 15. The company is expected to report a year-over-year rise in earnings and revenue. Therefore, should investors consider buying the stock pre-earnings? Read on to learn my view…
: SO |  News, Ratings, and Charts

Southern Co. (So): Buy or Watch Ahead of Earnings?

Utility major The Southern Company (SO) will release its fourth-quarter results on February 15. The company is expected to report a year-over-year growth in earnings and revenue. Therefore, should investors consider buying the stock ahead of its earnings? Read on to learn my view…
: AMAT |  News, Ratings, and Charts

Applied Materials (AMAT): Earnings Expectations and Strategies

Santa Clara, California-based Applied Materials will report its first-quarter results on February 15. The company is expected to report a year-over-year decline in earnings and revenue. How should investors position themselves before its earnings release? Read on to learn my view…
: CSCO |  News, Ratings, and Charts

Cisco Systems (CSCO): Buy or Hold Pre-Earnings?

San Jose, California-based network giant Cisco (CSCO) will release its second-quarter results on February 14. The company is expected to report a year-over-year decline in earnings and revenue. Therefore, should investors consider buying the stock pre-earnings? Read on to learn my view…
: MAR |  News, Ratings, and Charts

Marriott International (MAR) Earnings Alert: Buy or Sell Signals?

Marriott International (MAR) will release its fourth-quarter results on February 13. The company is expected to report year-over-year growth in earnings and revenue. Therefore, should investors consider buying the stock now? Read on to learn my view…
Page generated in 1.3964 seconds.